Enfuvirtide overdosage

Revision as of 03:30, 9 January 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Enfuvirtide}} {{CMG}}; {{AE}} {{SS}} ==overdosage== There are no reports of human experience of acute overdose with FUZEON. The highest dose administered to 12 su...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Enfuvirtide
FUZEON® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

overdosage

There are no reports of human experience of acute overdose with FUZEON. The highest dose administered to 12 subjects in a clinical trial was 180 mg as a single dose subcutaneously. There is no specific antidote for overdose with FUZEON. Treatment of overdose should consist of general supportive measures.[1]

References

  1. "FUZEON (ENFUVIRTIDE) KIT [GENENTECH, INC.]". Retrieved 9 January 2014.

Adapted from the FDA Package Insert.